Skip to main content
logo
Pulse Biosciences, Inc. (PLSE)
NASDAQ: PLSE · Real-Time Price · USD
53.29
+0.22 (0.41%)
At close: Nov 6, 2026, 4:00 PM EST
52.49
-0.80 (-1.50%)
After-hours: Nov 6, 2026, 7:30 PM EST

Pulse Biosciences Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1.490.35--0.71.42
Revenue Growth
1637.21%----50.63%-
Cost of Revenue
1.090.54--11.941.97
Gross Profit
0.4-0.19---11.24-0.55
Selling, General & Admin
30.6332.0323.9215.7825.9733.82
Research & Development
57.3444.7232.3427.820.8428.64
Operating Expenses
87.9776.7556.2643.5746.8162.46
Operating Income
-87.57-76.94-56.26-43.57-58.06-63.01
Interest Expense
----1.1-0.9-0.7
Interest & Investment Income
3.224.212.692.460.640.05
Other Non Operating Income (Expenses)
0.02-0.05-0.02---
EBT Excluding Unusual Items
-84.32-72.78-53.59-42.21-58.32-63.66
Gain (Loss) on Sale of Assets
-----0.19-
Pretax Income
-83.72-72.78-53.59-42.21-58.51-63.66
Net Income
-83.72-72.78-53.59-42.21-58.51-63.66
Net Income to Common
-83.72-72.78-53.59-42.21-58.51-63.66
Net Income Growth
------
Shares Outstanding (Basic)
696758503428
Shares Outstanding (Diluted)
696758503428
Shares Change
4.96%15.41%17.41%46.56%21.35%20.29%
EPS (Basic)
-1.21-1.08-0.92-0.85-1.72-2.28
EPS (Diluted)
-1.21-1.08-0.92-0.85-1.72-2.28
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-63.7-54.44-36.47-33.16-47.41-54.53
Free Cash Flow Per Share
-0.92-0.81-0.62-0.67-1.40-1.95
Gross Margin
26.77%-54.00%----38.79%
Operating Margin
-5861.24%-21982.57%---8293.86%-4443.87%
Profit Margin
-5603.88%-20794.57%---8357.86%-4489.42%
Free Cash Flow Margin
-4263.86%-15553.43%---6773.43%-3845.84%
EBITDA
-86.54-75.87-55.08-42.37-56.7-61.87
D&A For EBITDA
1.031.071.181.211.361.15
EBIT
-87.57-76.94-56.26-43.57-58.06-63.01
Revenue as Reported
----0.71.42
SEC Filings: 10-K · 10-Q